A systematic review of randomized trials comparing double versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention-Reference-Cited by-同舟云学术

A systematic review of randomized trials comparing double versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention

Published:2019-11-11 Issue:2 Volume:96 Page:
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Sullivan Alexander E.¹,Nanna Michael G.¹²^ORCID,Rao Sunil V.¹²,Cantrell Sarah³^ORCID,Gibson C. Michael⁴,Verheugt Freek W. A.⁵,Peterson Eric D.¹²,Lopes Renato D.¹²,Alexander John H.¹²,Granger Christopher B.¹²,Yee Megan K.⁴,Kong David F.¹²

Affiliation:

1. Section of Cardiovascular Medicine, Department of Medicine Duke University Medical Center Durham North Carolina

2. Duke Clinical Research Institute Duke University School of Medicine Durham North Carolina

3. Duke University School of Medicine Durham North Carolina

4. Department of Cardiology Beth Israel Deaconess Medical Center Boston Massachusetts

5. Department of Cardiology Onze Lieve Vrouwe Gasthuis (OLVG) Amsterdam The Netherlands

Funder

Center for Scientific Review

National Institutes of Health

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.28535

Reference26 articles.

1. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

2. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

3. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

4. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

5. Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Coronary Disease in Older Adults;Medical Clinics of North America;2024-05

2. Dual compared with triple antithrombotics treatment effect on ischemia and bleeding in atrial fibrillation following percutaneous coronary intervention: A meta-analysis;International Journal of Clinical Medical Research;2023-09-28

3. Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies;Health Technology Assessment;2023-05

4. The optimal duration of triple antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention: A network meta-analysis of randomized clinical trials;International Journal of Cardiology;2022-06

5. Non–Vitamin K Antagonist Oral Anticoagulants in Coronary Artery Disease;Hämostaseologie;2021-10-18